Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis
Anaphylaxis
About this trial
This is an interventional treatment trial for Anaphylaxis focused on measuring Mild -Moderate Anaphylaxis
Eligibility Criteria
Inclusion Criteria:
- All patients 3 monthes-14years presenting to the Pediatric Emergency Department (AlSadd) with mild to moderate anaphylaxis
Exclusion Criteria:
Patients with severe anaphylaxis. Patient with history of immunological diseases. Patients on steroids therapy Patient with moderate-severe asthma on medication Patients with severe asthma
Sites / Locations
- Hamad Medical CorporationRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Dexamethasone arm
Placebo arm
All patients will be Urgently treated for anaphylaxis according to guideline protocol. Enrolled patients will be given one of study medication orally, and he /she will observe in the observation room with cardiac monitor and close monitoring by nurse.
All patients will be Urgently treated for anaphylaxis according to guideline protocol. Enrolled patients will be given one of study medication orally, and he /she will observe in the observation room with cardiac monitor and close monitoring by nurse.